Navigation Links
Consolidation Among Chicago Physicians Likely to Increase
Date:8/25/2009

NASHVILLE, Tenn., Aug. 25 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while the medical community in Chicago is more consolidated than most large cities, with multiple large physician groups affiliated with health systems, the physician segment is likely to grow even more consolidated in the future. According to the recent Chicago Market Overview, with lower patient volumes, a higher percentage of uninsured patients and tighter access to capital, consolidation is likely for local physicians who have already been dealing with stagnant reimbursement from insurers and increased costs such as electronic medical records and malpractice insurance.

"While increased consolidation will provide Chicago physicians with additional resources and better leverage with insurers, it's not all positive for the medical community, particularly for those physicians who value greater independence," said Mark Cherry, analyst with HealthLeaders-InterStudy. "Such consolidation can also be a challenge for pharmaceutical sales representatives because health systems are more likely to require them to make appointments to see physicians."

Hospitals, looking for referral streams and added leverage against health plans, are eager to employ physicians. Additionally, greater consolidation gives health systems an increased ability to streamline clinical practices. One example of this consolidation trend is Chicago's Advocate Health Care's recent acquisition of Midwest Physician Group, a multispecialty practice that previously sent the majority of its patients to St. James Hospital.

"The consolidation among physician groups may be the first step in greater consolidation across the Chicago market, as the healthcare sector will be more aligned with two main segments: health systems and health plans," said Cherry. "Look for tensions between these two segments to increase."

Why Pharmaceutical Companies Need Market Overviews

Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                               Elizabeth Marshall
    HealthLeaders-InterStudy                  Decision Resources, Inc.
    781-296-2606                              781-296-2563
    losgood@hl-isy.com                        emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments
2. Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark
3. Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross
4. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
5. Akela Pharma Inc. Completes Share Consolidation
6. Blood Mercury Levels Rising Among U.S. Women
7. Better Pap Smear Follow-Up Needed Among Lower-Income Women
8. Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth
9. Cancer Deaths Declining, Especially Among Young
10. Carefxs New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients
11. Sharing Prescription Meds Common Among U.S. Teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and University ... Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate of ... she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
(Date:6/23/2016)... ... 23, 2016 , ... The U.S. Supreme Court decision on immigration has significant ... The Senior Citizens League (TSCL) . “President Obama’s executive actions on immigration would ... who worked in this country illegally, even though the newly - issued green cards ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: